Case number IPR2024-00260
Celltrion, Inc. et al. v. Regeneron Pharmaceuticals, Inc. > Related Cases
| Number | Title | Filing date |
|---|---|---|
| 1:22-cv-00061 | Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. | Aug 2, 2022 |
| IPR2022-01524 | Apotex Inc. et al. v. Regeneron Pharmaceuticals, Inc. | Sep 9, 2022 |
| IPR2023-00884 | Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc. | Apr 27, 2023 |
| 1:23-cv-00094 | Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD., | Nov 21, 2023 |
| 1:23-cv-00097 | Regeneron Pharmaceuticals, Inc. v. Formycon AG | Nov 29, 2023 |
| IPR2024-00298 | Biocon Biologics Inc. et al. v. Regeneron Pharmaceuticals, Inc. | Dec 18, 2023 |
| 2:24-cv-00264 | Regeneron Pharmaceuticals, Inc. v. Amgen, Inc. | Jan 10, 2024 |
| 1:24-cv-00039 | Regeneron Pharmaceuticals, Inc. v. Amgen, Inc. | Apr 16, 2024 |
| 1:24-cv-00053 | Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc. | May 17, 2024 |
